You can find the annual or quarterly income statement of Novabridge Biosciences ADR here for insights into the performance and operational efficiency of Novabridge Biosciences ADR.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

Total revenue

--0.00

Revenue

--0.00

Operating expenses

--8.99M

--7.11M

R&D expenses

--3.18M

--3.29M

Operating profit

---8.99M

---7.11M

Net non-operating interest income (expenses)

Non-operating interest income

--2.15M

--1.80M

Return on equity

--0.00

Other non-operating income (expenses)

--14.00K

---190.00K

Income before tax

---6.83M

---5.50M

Income tax

--0.00

Income after tax

---6.83M

---5.50M

Net income from continuous operations

---6.83M

---5.50M

Net income from discontinued operations

--0.00

Net income attributable to controlling interests

---6.83M

---5.50M

Net income attributable to common shareholders

---6.83M

---5.50M

Basic earnings per share

---0.03

Diluted earnings per share

---0.03

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

